Loading clinical trials...
Loading clinical trials...
A Phase I/II Clinical Trial Study on Autologous Erythrocytes Derived Microparticles Packaging Methotrexate Peritoneal Perfusion in the Treatment of Malignant Ascites
Conditions
Interventions
Erythrocytes derived MPs containing MTX
convention drugs
Locations
1
China
Hui ting Xu
Wuhan, Hubei, China
Start Date
May 1, 2017
Primary Completion Date
December 1, 2017
Completion Date
February 1, 2018
Last Updated
July 26, 2017
NCT06016179
NCT02122185
NCT05303844
NCT02477657
NCT00326885
NCT03200106
Lead Sponsor
Hui ting Xu，MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions